Getting your player ready...
COPENHAGEN — A Danish pharmaceutical company is changing its distribution system to stop one of its drugs from being used in U.S. executions, adding a significant obstacle for states that have scrambled recently to find a suitable lethal injection drug.
Lundbeck Inc. chief executive Ulf Wiinberg said Friday that his company will demand that U.S. distributors sign an agreement stating they will not make pentobarbital — a sedative with a number of uses — available for prisons using it for lethal injections.
A growing number of death- penalty states are using the sedative since the sole U.S. manufacturer of another key execution drug announced this year that it would not resume production of it.
Denver Post wire services
